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Nonhuman adenoviruses including porcine adenovirus serotype 3 (PAd3) are emerging vectors for gene delivery. PAd3 efficiently
transduces human and murine cells in culture, and circumvents preexisting humoral immunity in humans. The coxsackievirus–adenovirus
receptor (CAR) serves as a primary receptor and avh3 or avh5 integrin as a secondary receptor for several human adenovirus (HAd) subtypes
including HAd5. In this study, we deduced the role of CAR, avh3 or avh5 integrin in PAd3 internalization. Transduction experiments were
conducted in human mammary epithelial (MCF-10A) cells using replication-defective PAd-GFP (PAd3 vector expressing green fluorescent
protein [GFP]) and HAd-GFP (HAd5 vector expressing GFP). MCF-10A cells were treated with or without anti-human CAR, or anti-avh3 or
anti-avh5 integrin antibodies prior to infection with HAd-GFP or PAd-GFP. Significant (P b 0.05) inhibition in transduction by HAd-GFP
was observed in antibody-treated cells as compared to untreated cells, whereas transduction by PAd-GFP remained to similar levels
irrespective of the treatment. To study the adenoviral fiber knob-mediated virus interference, MCF-10A cells were treated with or without the
recombinant HAd5 or PAd3 knob followed by infection with HAd-GFP or PAd-GFP. Significant (P b 0.05) inhibition was observed only in
transduction of the homologous vector. These results suggested that PAd3 internalization was CAR- as well as avh3 or avh5 integrin-
independent and the primary receptor for HAd5 and PAd3 were distinct. CAR- and avh3 or avh5 integrin-independent entry of PAd3 vectors
may have implications in targeting cell types that are not efficiently transduced by other adenoviral vectors.
D 2004 Elsevier Inc. All rights reserved.
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High-affinity binding of the adenoviral fiber knob to the
coxsackievirus-adenovirus receptor (CAR) is the primary
event in virus internalization into the host cells (Bergelson et
al., 1997) for human adenovirus (HAd) serotype 5 (HAd5),
the widely studied HAd vectors for gene therapy. In fact,
CAR serves as a primary receptor for the majority of HAd in
subgroups A, C, D, E, and F but not B (Bergelson et al.,
1997; Roelvink et al., 1998; Tomko et al., 1997). CAR is a
46-kDa type I integral transmembrane protein belonging to0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.11.010
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E-mail address: mittal@purdue.edu (S.K. Mittal).the Ig superfamily (Bergelson et al., 1997). While its exact
cellular function is unknown, it appears that CAR might
serve as a cell adhesion molecule. Expression of CAR is
variable in human cell types (Tomko et al., 1997), and it
appears to be developmentally regulated (Honda et al.,
2000). In addition to CAR, several other cell surface
molecules, which have been implicated as primary receptors
for HAd include MHC class I a2 domain (Hong et al.,
1997), sialic acid saccharides (Arnberg et al., 2000), CD46
(Gaggar et al., 2003), CD80/CD86 (Short et al., 2004), and
heparan sulfate glycosaminoglycans (Dechecchi et al., 2000;
Smith et al., 2003).
Following CAR binding, the HAd penton base protein
interacts with vitronectin-binding integrins, specifically
avh3 and avh5, leading to receptor-mediated uptake of
virus particles (Hong et al., 1997; Wickham et al., 1993).05) 157–166
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(RGD) motif of the adenovirus penton base. The integrin-
binding RGD motif is also found in a number of adhesion
molecules that are known to interact with integrins (Bai et
al., 1993). It has been shown that the interaction of the HAd
penton base with integrin promotes actin cytoskeletal
reorganization via activation of several signaling molecules
(Li et al., 2001).
Due to ubiquitous nature of HAd, a majority of the
human population is exposed to one or more HAd
serotypes leading to the development of a HAd-specific
immune responses (Harvey et al., 1999). This preexisting
vector immunity significantly reduces the uptake of HAd
vectors following the first inoculation. The early region 1
(E1)-deleted replication-defective HAd vectors are capable
of expressing the early and late viral genes at a magnitude
sufficient to stimulate cellular and humoral immune
responses (Kafri et al., 1998; Yang et al., 1995). The
cellular immune response eliminates the target cells
expressing viral and transgene products, whereas neutral-
izing antibodies significantly inhibit virus uptake follow-
ing readministration of the same vector (Moffatt et al.,
2000; Sailaja et al., 2002; Walter et al., 1996). This leads
to a rapid loss of transgene expression in experimental
animals (Crystal, 1995). In order to elude preexisting
vector immunity and to effectively transduce cell types
that are poorly infected by HAd5 vectors, a number of
human and nonhuman adenoviruses, such as HAd35
(Reddy et al., 2003), bovine adenovirus serotype 3
(BAd3) (Mittal et al., 1995; Reddy et al., 1999), canine
adenovirus serotype 2 (Hemminki et al., 2003; Klonjkow-
ski et al., 1997; Kremer et al., 2000), chimpanzee
adenovirus (Farina et al., 2001; Xiang et al., 2002), ovine
adenovirus (Hofmann et al., 1999; Loser et al., 2003), and
porcine adenovirus serotype 3 (PAd3) (Bangari and Mittal,
2004; Reddy et al., 1999; Zakhartchouk et al., 2003) have
been developed.
PAd3 is a Mastadenovirus and was originally isolated
from a healthy piglet (Clarke et al., 1967) and is not
known to cause any serious disease in its natural host
(Derbyshire et al., 1975). Its genome organization and the
transcription map are similar to those of subtype C HAd
(Reddy et al., 1998). PAd3 has been shown to effectively
circumvent the HAd-specific immune response (Moffatt et
al., 2000). HAd-specific preexisting neutralizing antibodies
in humans did not cross-neutralize PAd3 (Bangari and
Mittal, 2004), and PAd3 vectors efficiently transduce both
human and murine cells in culture (Bangari and Mittal,
2004). We observed that the transduction efficiency of a
PAd3 vector in mouse NIH 3T3 cell line was significantly
higher than that of a HAd5 vector (Bangari and Mittal,
2004), suggesting that these two vectors may use different
primary receptors for receptor-mediated internalization.
Since HAd5 vectors enter susceptible cells via CAR-
mediated endocytosis and NIH 3T3 cells are known to
express low level of CAR, these results indicated thatPAd3 entry into these cells might be CAR-independent.
The nature of primary receptor(s) for PAd3 is unknown.
Since the PAd3 penton base lacks the integrin binding
RGD motif (Reddy et al., 1998), the nature of secondary
interactions in PAd3 internalization is not clear. The
present study shows that PAd3 internalization in MCF-
10A cell line (originated from human normal breast
epithelial cells) is independent of CAR and avh3 or avh5
integrin. The results of fiber knob-mediated virus interfer-
ence studies using the recombinant HAd5 or PAd3 fiber
knob domain suggest that the receptor(s) for HAd5 and
PAd3 internalization into susceptible cells are distinct.Results
Comparative sequence analysis of PAd3 and HAd5 fiber
knobs
While entry of HAd5, HAd2, and several other HAd
serotypes is mediated by their initial binding to CAR
(Bergelson et al., 1997), receptors involved in PAd3
attachment and internalization are currently unknown.
Our recent observation demonstrates that PAd-GFP effi-
ciently transduce NIH 3T3 cells, a low CAR expressing
cell line (Bangari and Mittal, 2004), suggesting that PAd3
vector entry into this cell line may be CAR-independent.
Since the adenoviral fiber knob domain is believed to
initiate virus binding on the cell surface, we began with a
comparison of deduced amino acid sequences of PAd3 and
HAd5 fiber knob domains. Based on the structural and
mutagenesis studies of knob domains of various CAR-
binding HAd subtypes, amino acid residues that are
critical for CAR binding have been identified (Kirby et
al., 2000; Roelvink et al., 1998). Comparative sequence
analysis of the fiber knob domains of PAd3 and HAd5
(Fig. 1) revealed that the residues critical in CAR-binding
(Ser408, Pro409, Tyr477, and Leu485) or those that periph-
erally influence CAR-binding (Ala406, Arg412, and Arg481)
were not conserved in the PAd3 fiber knob (Fig. 1). The
Thr-Leu-Trp-Thr (TLWT) motif that marks the beginning
of the knob domain in most Mastadenovirus species
(Chroboczek et al., 1995) was conserved in the PAd3
fiber, but there was only 23.1% amino acid sequence
similarity with the PAd3 fiber knob compared to its HAd5
counterpart. Furthermore, the PAd3 fiber is expected to be
shorter (448 residues with 15 repeats in the shaft region)
(Reddy et al., 1995, 1998), compared to the HAd5 fiber
(581 residues with 22 repeats in the shaft region)
(Chroboczek et al., 1995). Moreover, the integrin-binding
motif such as the classical Arg-Gly-Asp (RGD) or Leu-
Asp-Val (LDV) motif is not present in the PAd3 penton
base (Reddy et al., 1998). In the light of these striking
differences at the amino acid sequence level, we hypothe-
sized that PAd3 internalization into susceptible cells may
be CAR- as well as integrin-independent.
Fig. 1. Homology comparison of the HAd5 fiber knob with the corresponding region of PAd3 fiber using CLUSALW alignment software. Identical, similar,
and related residues are indicated by asterisks, colons, and dots, respectively. The HAd5 fiber knob residues that are known to be critical for CAR binding or
that peripherally affect CAR binding are in bold or are underlined, respectively.
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In order to conduct CAR-blocking experiments, we
needed a cell line, which was efficiently transduced by
both PAd3 and HAd5 vectors, and expressed moderate
levels of CAR. Although our focus was to determine
whether CAR or integrins play a role in PAd3 internal-
ization, we included HAd-GFP as a control to validate our
experimental methodology. Initially, we compared expres-
sion levels of CAR in a number of cell lines of human,
murine, porcine, or bovine origin by immunofluorescence
and Western blot using an anti-CAR polyclonal antibody.
We observed significant differences in expression levels of
CAR in various human and nonhuman cell lines. The
human embryonic kidney (293), fetal bovine retinal (FBRT
HE1), and murine breast tumor (MT1A2) cell lines appeared
to be high-CAR expressing; human malignant breast cancer
(MDA-MB231), human mammary epithelial (MCF-10A),
and fetal porcine retinal (FPRT HE1-5) cells as intermedi-
ate-CAR expressing; and the mouse fibroblast (NIH 3T3)
cell lines as low-CAR expressing cells as detected by
immunofluorescence assay (Fig. 2A) and Western blot (Fig.
2B). On the basis of our previous finding that transductionFig. 2. Level of CAR expression in various cell lines. (A) Various cell lines of hu
bovine [FBRT-HE1-1], and porcine [FPRT-HE1-5] origin were grown to appr
formaldehyde, and analyzed by immunofluorescence assay using a rabbit anti-hum
microscope. (B) Various cell lysates were resolved by SDS-PAGE, transferred to a
rabbit anti-human CAR antibody and a secondary HRP-conjugated anti-rabbit ant
Station.efficiencies of HAd-GFP and PAd-GFP in MCF-10A cell
line were approximately 83% and 88%, respectively
(Bangari and Mittal, 2004), and the results of levels of
CAR expression shown here, this cell line was chosen for
the present study.
To further confirm the expression of CAR, and to
determine the expression of arh3 or arh5 integrin in
MCF-10A cells, we performed flow cytometric analysis
using an anti-human CAR (hCAR), or anti-arh3 integrin or
anti-arh5 integrin antibody. The results demonstrated that
MCF-10A cells expressed CAR (Fig. 3A), arh3 integrin,
and arh5 integrin (Fig. 3B). Of these three cell surface
molecules, arh5 integrin appeared to be in most abundance.
CAR- and integrin-independent transduction by PAd-GFP
Having confirmed the presence of the CAR, arh3
integrin, and arh5 integrin on MCF-10A cells, we sought
to determine the effect of antibody-mediated blocking of
these cell surface molecules on the transduction ability of
PAd-GFP. The mouse monoclonal antibody, RmcB, is
known to bind CAR receptors on the cell surface and
thereby block infection of subtype C and other CAR-man [293, MDA-MB-231 and MCF-10A], murine [MT1A2 and NIH 3T3],
oximately 75% confluence on the Lab-tek chambered slide, fixed with
an CAR antibody. The slides were visualized at 200 under a fluorescence
nitrocellulose membrane and analyzed by Western blot using a polyclonal
ibody. The signal was detected by chemiluminescence using Kodak Image
Fig. 3. Flow cytometric analysis for CAR, arh3 integrin or arh5 integrin expression on MCF-10A cells. MCF-10A cells were harvested and analyzed for the
presence of CAR, arh3 integrin or arh5 integrin molecules using a CAR-, arh3 integrin-, or arh5 integrin-specific antibody and an FITC-labeled secondary
antibody followed by flow cytometry. Unstained cells or the cells stained only with the secondary antibody served as negative controls.
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We observed a drastic inhibition in HAd-GFP transduction
of MCF-10A cells preincubated with various concentrations
of RmcB (Fig. 4). More than 50% reduction in theFig. 4. Ablation of CAR-mediated internalization using a CAR-specific
antibody. MCF-10A cells in monolayer cultures were treated with 1, 5, or
25 Ag/ml of CAR-specific antibody at 4 8C for 1 h followed by infection
either with HAd-GFP or PAd-GFP at an m.o.i. of 20 p.f.u. per cell. At 36 h
post-infection, cells were harvested by trypsinization and the cells
expressing GFP were sorted by flow cytometry. Cell monolayers treated
without the CAR-specific antibody but were infected similarly with HAd-
GFP or PAd-GFP served as positive controls. The transduction efficiencies
of positive controls were taken as 100% for calculating relative transduction
of various treatment groups. The results are shown as the mean F standard
deviation of the percent relative transduction of at least three independent
observations. *, P b 0.05.transduction efficiency of HAd-GFP was observed at the
lowest concentration of RmcB antibody (1 Ag/ml) used in
our experiment. Further reduction in transduction efficiency
was observed at higher concentrations of RmcB. This
finding supported the pre-established paradigm of CAR-
mediated entry of HAd5 (Bergelson et al., 1997; Tomko et
al., 1997). Interestingly, RmcB blocking of CAR molecules
on MCF-10A cells did not significantly (P b 0.05) affect the
transduction efficiency of PAd-GFP (Fig. 4), thus implying
a CAR-independent entry pathway for PAd3. We also
conducted adenoviral vector transduction experiments with
an m.o.i. of 1 or 5 p.f.u. per cell of HAd-GFP or PAd-GFP
following antibody-mediated blocking of CAR and found
that the inhibitory effect on HAd-GFP transduction
remained to similar levels (data not shown). These experi-
ments were also conducted in MDBK (Madin Darby bovine
kidney) cell line with similar results (data not shown).
Next, we tested if the function-blocking antibody against
arh3 or arh5 integrin could affect infectivity of PAd-GFP.
Since integrins have been suggested as secondary receptors
mediating HAd5 internalization (Wickham et al., 1993), it
was expected that preincubation of cells with an anti-arh3
or anti-arh5 integrin antibody would diminish HAd5
infectivity. To rule out the possibility that CAR-binding
itself was sufficient to mediate internalization, we per-
formed all anti-integrin antibody-mediated blocking assays
in the presence of the anti-CAR antibody. MCF-10A cells
were incubated with RmcB antibody (20 Ag/ml) prior to
the addition of 10 or 25 Ag/ml of an anti-arh3 or anti-
arh5 integrin antibody. Significant (P b 0.05) dose-
dependent inhibition in HAd-GFP transduction was
observed and the effect was more pronounced with the
anti-arh3 integrin antibody (Fig. 5A) than with the anti-
arh5 integrin antibody (Fig. 5B). This difference could
partly be attributed to the low abundance of arh3 integrin
molecules on MCF-10A cells (Fig. 3B). Importantly, no
significant (P N 0.05) inhibition in PAd-GFP infectivity
was noticed with either antibody. These data indicated that
PAd3 did not use CAR, arh3 integrin, or arh5 integrin for
internalization.
Fig. 5. Ablation of arh3 integrin- or arh5 integrin-mediated internalization using specific antibodies. MCF-10A cells in monolayer cultures were treated with
a fixed amount of RmcB antibody (20 Ag/ml) and (A) arh3 integrin-specific (10 or 25 Ag/ml) or (B) arh5 integrin-specific (10 or 25 Ag/ml) antibody at 4 8C
for 1 h followed by infection either with HAd-GFP or PAd-GFP at an m.o.i. of 20 p.f.u. per cell. At 36 h post-infection, cells were harvested by trypsinization
and the cells expressing GFP were sorted by flow cytometry. Cell monolayers treated without the specific antibody but were infected similarly with HAd-
GFP or PAd-GFP served as positive controls. The transduction efficiencies of positive controls were taken as 100% for calculating relative transduction of
various treatment groups. The results are shown as the mean F standard deviation of the percent relative transduction of at least three independent
observations. *, P b 0.05.
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PAd-GFP by homologous fiber knob
Competitive inhibition of adenoviral binding and inter-
nalization by the soluble viral fiber or knob domain has been
utilized as the most convincing evidence for the distinct
receptor usage by various HAd serotypes (Arnberg et al.,
2000; Bergelson et al., 1997; Philipson et al., 1968;
Roelvink et al., 1998). The primary receptor seeking moiety
of the adenovirus resides in the fiber knob (Henry et al.,
1994). Therefore, preincubation of susceptible cells with
soluble trimeric knobs leads to saturation of the virus
receptors resulting in a dose-dependent inhibition in the
parent (homologous) virus attachment and infectivityFig. 6. Expression and specificity of recombinant H5 and P3 knobs. (A) Purified
dithiothreitol treatment were analyzed by SDS-PAGE and stained with Coomassie b
were conducted using (B) anti-HAd5 or (C) anti-PAd3 hyperimmune serum. Trim(Bergelson et al., 1997; Henry et al., 1994). We needed
both HAd5 and PAd3 trimeric knob domains to pursue virus
interference studies. Both the monomeric and the trimeric
forms of purified PAd3 knob (P3 knob) and HAd5 knob (H5
knob) were observed on SDS-PAGE gels stained with
Coomassie blue (Fig. 6A). The expected molecular weights
of P3 and H5 knob monomers were 20.9 and 19.8 kDa,
respectively. The knob trimers seen on stained gels were
confirmed to be specific by Western blot using virus-
specific rabbit hyperimmune sera (Figs. 6B,C), indicating
that recombinant P3 and H5 knobs were capable of
trimerization into functionally active forms.
Inability of anti-CAR antibody to inhibit transduction of
PAd-GFP suggested that the primary receptor for HAd5 andrecombinant H5 and P3 knob proteins with (boiled) or without (unboiled)
lue. Western blot analyses of purified recombinant H5 and P3 knob proteins
ers (Y), monomers ( S ).
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homologous and heterologous competition experiments in
order to confirm this finding. MCF-10A cells were
incubated with various concentrations of recombinant H5
or P3 knob domain to saturate their respective primary
receptors prior to infection with HAd-GFP or PAd-GFP. As
expected, the H5 knob domain significantly (P b 0.05)
inhibited HAd-GFP transduction in MCF-10A cells in a
dose-dependent manner, whereas there was no significant
(P N 0.05) inhibition in PAd-GFP transduction even at the
highest concentration of the H5 knob domain. HAd-GFP
transduction was reduced to approximately 40% in cells
preincubated with 25 Ag/ml of the H5 knob (Fig. 7A).
Similarly we observed a significant (P b 0.05) dose-
dependent inhibition in PAd-GFP transduction in MCF-
10A preincubated with the P3 knob (Fig. 7B), while HAd-
GFP transduction was not significantly (P N 0.05) affected.
Interestingly, higher concentrations of P3 knob were needed
to obtain similar levels of inhibition in transduction with
homologous vector as compared to those of H5 knob. This
may be attributed to high abundance of PAd3 receptor(s)
compared to CAR on MCF-10A cells.Discussion
Although PAd3 has been used as a vaccine vector in
swine (Hammond et al., 2001) and is being developed as a
potential gene delivery vector (Bangari and Mittal, 2004),
its tissue tropism and the determinants of cell entry have notFig. 7. Ablation of CAR-mediated internalization using the recombinant HAd5 or P
1, 5, or 25 Ag/ml of the recombinant HAd5 fiber knob or (B) 1, 5, 25, or 75 Ag/m
either with HAd-GFP or PAd-GFP at an m.o.i. of 20 p.f.u. per cell. At 36 h post-in
were sorted by flow cytometry. Cell monolayers treated without the recombinant
served as positive controls. The transduction efficiencies of positive controls we
groups. The results are shown as the mean F standard deviation of the percent rebeen investigated. Among various HAd subtypes, there are
significant differences in the fiber structure, both in the
overall fiber shaft length and the amino acid composition
(Roelvink et al., 1999) accounting for the differences in their
tissue tropism. This is supported by the fact that different
serotypes preferentially infect different tissue types in
human and animals, including the ocular, respiratory,
gastrointestinal, and genitourinary tissues (Mei et al.,
1998). PAd3 was originally isolated from the rectal swab
(Clarke et al., 1967), whereas HAd5 is known to infect the
respiratory system (Horwitz, 2001). A comparison of the
receptor-binding knob domain of PAd3 fiber with that of
HAd5 revealed that the residues involved in CAR binding
were not conserved in the PAd3 fiber knob, while most of
the CAR-binding HAd subtypes show conservation at these
CAR-binding residues (Roelvink et al., 1999). Therefore,
we anticipated that PAd3 internalization into susceptible
cells might be independent of CAR expression on the cell
surface. Our results clearly demonstrated that antibody-
mediated blocking of CAR molecules on the cell surface did
not affect PAd-GFP transduction, while HAd-GFP trans-
duction was substantially reduced.
In addition to CAR, various integrins are believed to be
involved as secondary receptors for HAd5 entry. The
integrin-binding RGD or LDV motif is absent in the penton
base of PAd3, suggesting that interaction with integrin
molecules may not be important for PAd3 internalization.
However, it has been suggested that adenovirus could bind
integrins even in the absence of the RGD motif (Soudais et
al., 2000). Our study involving the antibody-mediatedAd3 fiber knob. MCF-10A cells in monolayer cultures were treated with (A)
l of the recombinant PAd3 fiber knob at 4 8C for 1 h followed by infection
fection, cells were harvested by trypsinization and the cells expressing GFP
HAd5 fiber knob but were infected similarly with HAd-GFP or PAd-GFP
re taken as 100% for calculating relative transduction of various treatment
lative transduction of at least three independent observations. *, P b 0.05.
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reduce PAd-GFP transduction as compared to HAd-GFP
transduction. It has been shown that human HeLa and A549
cell lines that efficiently expressed CAR, avh3 integrin, and
avh5 integrin (Davison et al., 2001; Soudais et al., 2000)
were poorly transduced with PAd3 (Zakhartchouk et al.,
2003), whereas, murine NIH 3T3 cells that poorly expressed
CAR, avh3 integrin, and avh5 integrin were efficiently
transduced with PAd3 (Bangari and Mittal, 2004; unpub-
lished data). These observations and the fact that the RGD
or LDV motif is absent in the PAd3 penton base clearly
suggest that avh3 or avh5 integrin might not play a
significant role in PAd3 internalization. In addition, our
fiber-knob-mediated virus interference experiments using
the recombinant H5 or P3 knob showed that there was no
inhibition in vector transduction with the heterologous virus,
indicating that the primary receptor(s) for PAd3 and HAd5
were distinct.
A variety of cell surface molecules other than CAR have
been implicated in adenoviral binding and internalization.
Cell surface major histocompatibility (MHC) class I
molecules bind HAd5 knob (Hong et al., 1997); heparan
sulfate glycosaminoglycans (HSG) can interact with the
fiber shaft of HAd subtypes 2 and 5 (Dechecchi et al., 2000;
Smith et al., 2003); sialic acid has been shown to mediate
attachment and infection of adenovirus in subgroup D
(Arnberg et al., 2000); CD46 has been implicated as a
receptor for adenoviruses of subgroup B (Gaggar et al.,
2003); and recently CD80 and CD 86 have been shown to
be the attachment receptors for HAd3 (Short et al., 2004).
The role of any of these molecules as the primary PAd3
receptor/s is yet to be explored, but CD46 may not be
important in PAd3 internalization since PAd3 efficiently
transduced murine fibroblast cells, which are known to be
deficient in CD46.
Taken together, the results of this study suggest that
PAd3 entry in human MCF-10A cells is CAR- as well as
avh3 or avh5 integrin-independent and the primary recep-
tors for HAd5 and PAd3 are different. Cellular tropism is
one of the important factors that determine the usefulness of
viral vectors for gene delivery. Promiscuous transduction of
nontarget tissues, and poor transduction of several clinically
relevant tissue types including many cancers with HAd5
vectors is largely attributed to the CAR-dependent tropism
of HAd (Hemminki and Alvarez, 2002). Some of the
strategies to ablate CAR-dependent tropism of HAd vectors
include development of chimeric vectors carrying fibers
from non-CAR-binding adenoviruses such as HAd35
(Koizumi et al., 2003; Shayakhmetov et al., 2004),
HAd16 (Goossens et al., 2001), or HAd3 (Kanerva et al.,
2002) as well as from nonhuman adenoviruses such as
canine adenovirus serotype 2 (Glasgow et al., 2004), bovine
adenovirus serotype 4, duck adenovirus type 1, and fowl
adenovirus type 1 (Renaut et al., 2004). As reported in this
paper, CAR-independent entry of PAd3 should expand the
possibility of developing novel vectors with an extended ormodified tropism by engineering the chimeric PAd/HAd
knob or fiber.
To harness the potential of PAd3 vectors for application
in human gene delivery, it will be important to determine the
repertoire of cell types transduced by PAd3 vectors and
whether these vectors can efficiently transduce cell types,
which are refractory to HAd5 transduction. In vivo studies
in experimental animals will be necessary to explore
whether biodistribution of PAd3 vectors is different than
that of HAd5. It is anticipated that CAR-independent entry
of PAd3 may significantly lower the innate immune
response and hepatotoxicity, which are commonly observed
with a number of HAd vectors.Materials and methods
Adenoviral genome sequence alignment
The complete genomic sequences of HAd5 (accession
no. NC_001405) and PAd3 (accession no. AF083132) were
obtained from GenBank to compare amino acid sequences
of their receptor-binding fiber knob domains using CLU-
SALW alignment software (Thompson et al., 1994).
Cells and viruses
Various cell lines used in this study were as follows:
human embryonic kidney (293), human mammary epithe-
lium (MCF-10A), human malignant breast cancer (MDA-
MB231), murine fibroblast (NIH 3T3), murine breast cancer
(MT1A2) (Addison et al., 1995), fetal bovine retina (FBRT
HE1) (van Olphen et al., 2002), and fetal porcine retina
(FPRT HE1–5) (Bangari and Mittal, 2004). These cell lines
were propagated as described previously (Bangari and
Mittal, 2004). The construction of replication-defective
HAd5 (HAd-GFP) and PAd3 (PAd-GFP) vectors carrying
the green fluorescent protein (GFP) gene driven by the
cytomegalovirus promoter is described elsewhere (Bangari
and Mittal, 2004). These vectors were propagated and
purified as described previously (Bangari and Mittal, 2004).
Antibodies
A rabbit polyclonal antibody against human CAR
(hCAR) (Santa Cruz Biotechnology, Inc. Santa Cruz, CA)
was used for Western blot and immunofluorescence assays.
For blocking studies, the mouse hybridoma RmcB that
expresses anti-hCAR antibody (Hsu et al., 1988) was
purchased from ATCC and propagated as per supplier’s
recommendations. This monoclonal antibody was purified
from the hybridoma supernatant by protein G-sepharose
(Zymed Laboratories, Inc., San Francisco, CA) affinity
column chromatography following the manufacturer’s
instructions. The antibody concentration was determined
by Coomassie Blue Protein Assay Reagent (Pierce Bio-
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bovine serum albumin (BSA; 0.1%) were added to the
purified antibody for prolonged storage. For determining
integrin expression and function blocking assays, the mouse
anti-human arh3 integrin (clone LM609) and the mouse
anti-human arh5 integrin (clone P1F6) monoclonal anti-
bodies (Chemicon International, Inc., Temecula, CA) were
used.
Expression, purification, and characterization of
recombinant PAd3 and HAd5 fiber knobs
PAd3 fiber sequences encoding the knob domain and the
last shaft motif between nucleotides 29656 and 30285
(corresponding to the PAd3 genome sequence in GenBank
accession no. AF083132) was amplified by PCR using the
forward 5V-TGGATCCGACTTTCCTGTGGACAAT-3Vand
the reverse 5V AAGCTTTCATTGGAGTACTTGA-3V pri-
mers, and the genomic PAd3 DNA as a template. The PCR
product was ligated into the BamHI–HindIII site of pQE30
vector (Qiagen, Inc., Valencia, CA) to obtain pQE30.P3
knob, and expressed in E. coli M5 (pREP4) (Qiagen)
following the supplier’s recommendations. Briefly, the
bacterial culture was grown to an OD600 of 0.5–0.6 followed
by induction of protein expression by 1 mM isopropyl h-d-
thiogalactopyranoside (IPTG) and the incubation was
continued for 3–4 h at 37 8C. Due to the presence of the
6 His-tag in-frame with the knob, the recombinant protein
was purified from the soluble fraction by nickel-nitrilotri-
acetic acid (Ni-NTA) metal chelation chromatography using
His.Bind protein purification kit (Novagen, Madison, WI) as
per supplier’s instructions.
The plasmid pQE30.H5 knob that contains the HAd5
fiber knob domain sequence along with the last shaft motif
(Krasnykh et al., 1996) was generously provided by David
T. Curiel, University of Alabama, Birmingham, AL.
Recombinant HAd5 knob (H5 knob) was expressed and
purified from the soluble fraction as described above for the
P3 knob.
Purified knobs were dialyzed against PBS (137 mM
NaCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, and 2.7 mM KCl,
pH 7.4) and protein concentrations were determined by
Coomassie Protein Assay Reagent (Pierce) using BSA as a
standard. The ability of the recombinant P3 or H5 knob to
form trimers was verified using both boiled and unboiled
samples followed by Coomassie staining of SDS-PAGE gels
and Western blot using a rabbit anti-PAd3 or anti-HAd5
hyperimmune serum (Moffatt et al., 2000).
Western blot for CAR
Crude cell lysates were resolved by SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane
was blocked with the blocking buffer made with 4%
skimmed milk powder in TBS (150 mM sodium chloride,
10 mM Tris–Cl, pH 8.0 and 0.05% Tween-20) followed byincubation with a 1:100 dilution of a rabbit polyclonal anti-
hCAR antibody in the blocking buffer for 1 h at room
temperature. After washing the membrane in TBS for 30
min, the membrane was incubated for 1 h with a 1:2000
dilution of an HRP-conjugated goat anti-rabbit IgG (Bio-
Rad Laboratories, Hercules, CA). After the final wash, the
signal was detected by chemiluminescence using Enhanced
Chemiluminescence Assay Reagent (Pierce) and Kodak
Image Station (Eastman Kodak Co., Rochester, NY).
Antibody-mediated blocking experiments
To examine the ability of an anti CAR antibody to block
transduction by HAd-GFP or PAd-GFP, MCF-10A cells
grown to approximately 90% confluence in 12-well tissue
culture plates, were incubated with various concentrations
of the anti-CAR monoclonal antibody (RmcB) in 100 Al
PBS–BSA (PBS containing 1% BSA) for 45 min at 4 8C.
PAd-GFP or HAd-GFP was added at a multiplicity of
infection (m.o.i.) of 20 plaque forming units (p.f.u.) per cell
in 100 Al PBS++ (PBS containing 0.1% MgCl2 and 0.1%
CaCl2) and incubated at 37 8C for 45 min. The cells were
then washed once with PBS and supplemented with
minimum essential medium (MEM) containing 2% fetal
calf serum (FCS; Hyclone, Logan, UT) and incubated
further at 37 8C. At 36 h post-infection, the cells were
trypsinized, resuspended in PBS, and the cells expressing
GFP were sorted by flow cytometry. For blocking studies
using anti-integrin antibodies, cells were preincubated with
RmcB (20 Ag/ml) for 30 min at 4 8C prior to the addition of
indicated concentrations of an anti-arh3 or anti-arh5
antibody. After 45-min incubation at 4 8C, virus infection
followed by sorting of GFP expressing cells was carried out
as above.
Fiber-knob-mediated virus interference assays
To analyze the ability of recombinant P3 or H5 knob to
competitively inhibit transduction of homologous and
heterologous adenoviral vectors, MCF-10A cells in 12-well
plate were incubated with increasing concentrations of the
recombinant H5 or P3 knob in 100 Al PBS–BSA for 45 min
at 4 8C. PAd-GFP or HAd-GFP was added at an m.o.i. of 20
p.f.u./cell in 100 Al PBS++ and further incubated at 37 8C
for 45 min. The cells were then washed once with PBS and
supplemented with MEM containing 2% FCS and incubated
further at 37 8C. Cells were trypsinized at 36 h post-
infection and the cells expressing GFP were sorted by flow
cytometry.
Immunofluorescence labeling and flow cytometry
Approximately 106 MCF-10A cells, in 100 Al staining
buffer (PBS with 2% inactivated FCS and 0.1% sodium
azide), were incubated with the primary (anti-CAR, anti-
avh3, or anti-avh5) antibody (10 Ag/ml) for 30 min at 4 8C.
D.S. Bangari, S.K. Mittal / Virology 332 (2005) 157–166 165After two washes with the staining buffer, cells were
incubated in 100 Al of a FITC-conjugated goat anti-mouse
antibody (Jackson ImmunoResearch Laboratory, Inc., West
Grove, PA) (10 Ag/ml) for 30 min at 4 8C. Cells were then
washed twice with the staining buffer and analyzed by flow
cytometry. Unstained cells or the cells stained only with the
secondary antibody served as negative controls.
Analysis of GFP expression by flow cytometry
Flow cytometry analyses were performed essentially as
described (Bangari and Mittal, 2004). Briefly, cells were
trypsinized, washed once with PBS, and resuspended at a
density of approximately 106 cell per milliliter in PBS
containing 2% formaldehyde and immediately used for flow
cytometry at Purdue University Flow Cytometry Laborato-
ries using Cytomics FC-500 Flow Cytometer (Beckman
Coulter, Inc., Fullerton, CA) with Ar 488-nm excitation
filter and FL-1 525 nm BP emission filter. For each sample,
at least 5000 cells were counted.
Statistical analysis
Data were compared by Student’s t test for statistical
significance. P b 0.05 was considered significant.Acknowledgments
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